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HIV-1 Tat protein, acting at the cell membrane, stimulates the production by human monocytes of TNF-a, a cytokine implicated in both
HIV-1 replication and pathogenesis. Here, we analyze, in primary human monocytes, the mechanisms involved in Tat-stimulated calcium
mobilization and its relationship with TNF-a production. We show that the Tat protein induces a calcium signal by mobilizing calcium from
extracellular stores. This calcium signal is totally blocked when cells are stimulated in the presence of DHP receptor inhibitors such as
nimodipine or calcicludine, thus suggesting the implication of this L-type calcium channel. By using RT-PCR amplification, Western blot
with antibodies directed against the a1D subunit, binding assays with specific agonists or antagonists, and inhibition with specific antisense
oligonucleotides, we show that DHP receptors are expressed and functional in primary human monocytes. Interestingly, we demonstrate that
Tat-induced calcium mobilization is tightly linked to TNF-a production, thus indicating that Tat-induced mobilization and TNF-a production
are entirely mediated by DHP receptors, as shown by their total inhibition by nimodipine, calcicludine, or anti-a1D antisense
oligonucleotides.
D 2004 Elsevier Inc. All rights reserved.
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HIV-1 principally infects CD4+ lymphocytes, mono-
cytes/macrophages, and dendritic cells (Cameron et al.,
1996; Fauci, 1988). This infection results in profound and
selective depletion of CD4+ T cells during progression to
AIDS. However, before CD4+ T-lymphocyte depletion in
HIV-1-infected patients, a generalized immune dysfunction
is observed, which impairs a variety of immune functions,
including both specific and innate immunity. This immune
disorder is associated mainly with the loss of the T-cell0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.11.032
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E-mail address: bahraoui@cict.fr (E. Bahraoui).proliferative response to stimulation with recall antigens and
with the alteration of the Th1/Th2 balance of cytokines,
including TNF-a, IL-1, IL-4, IL-6, IL-10, and IL-12 (Clerici
and Shearer, 1993; Clerici et al., 1994; Emilie et al., 1994,
Graziosi et al., 1994; Poli, 2002). Several studies have
suggested that, during infection, HIV-1 patients develop a
progressive loss of the Th1 cellular immune response, the
most potent effector against viruses. In parallel to the
decrease in Th1 response, an increase in the Th2 immune
response was observed, but this seems to be inefficient
against HIV-1 infection.
In agreement with this finding, HIV-1-infected patients
have been reported to have high levels of TNF-a in sera,
brain (Wesselingh et al., 1993), and in vitro in supernatants
of monocytes, PBMC, and alveolar macrophages from05) 316–328
X. Contreras et al. / Virology 332 (2005) 316–328 317AIDS patients (Wright et al., 1988). Moreover, several
studies have demonstrated that TNF-a plays a major role in
progression to AIDS: it does so by acting directly on HIV-1
replication through activation of NF-nB (Duh et al., 1989)
and indirectly through cytotoxicity mediated by alteration of
the cellular redox state (Folks et al., 1989; Westendorp et al.,
1995a). Our group and others have shown that the HIV-1
Tat protein induces TNF-a production in monocytes and
macrophages (Bennasser and Bahraoni, 2002; Bennasser et
al., 2002; Chen et al., 1997; Mayne et al., 2000).
Tat, a 14-kDa protein containing 86–101 amino acids
encoded by two exons, is known for its transactivating
activity. Its absence can be complemented in trans and is
essential for efficient HIV-1 viral replication. Tat binds to
the secondary structure sequence Tat activation region
(TAR) at the 5Vterminus of viral RNA during transcription.
It thereby enables the recruitment of cellular factors, thus
constituting the complex cyclin T1/cdk 9, known as Tat-
associated kinase (TAK), that phosphorylates the C-
terminal domain of RNA polymerase 2, thereby activating
transcription elongation. Tat also participates in the patho-
genesis of HIV-1 infection by its ability to interact with
different cell types and alters the complex network of
cytokines involved in the regulation of the immune
response. Tat is found in nanomolar concentrations in the
serum of HIV-1-infected patients. It is secreted by infected
cells and can act on other cells, infected or not. Thus, Tat
contributes to immune system disorders, induces apoptosis
of T lymphocytes (Westendorp et al., 1995b), inhibits
MHC class I expression (Weissman et al., 1998), alters NK
cell activity (Zocchi et al., 1998), and inhibits IL-12Fig. 1. Analysis of the intracellular variation of calcium concentration by m
preincubated with fluo-3-AM (5 AM) for 30 min before microscopic observation.
(10 and 100 nM) at the time indicated by the arrows. Relative fluorescence corresp
emitted by resting cells. Each panel is a representative result of three independe
Monocytes preincubated for 30 min with fluo-3-AM were observed with a confo
Images with pseudocolors represent fluorescence variations in resting monocytes (
to the maximum response (t = 6 min for 10 nM Tat and t = 4 min for 100 nM Tat).
Similar results were obtained using HIV-1 SF-2 Tat.production by dendritic cells and monocytes (Poggi et al.,
1998).
We have previously shown that TNF-a and IL-10
production by human monocytes stimulated by Tat is,
respectively, totally and partially dependent on the presence
of calcium in the extracellular medium. A variety of cell
functions, including gene expression, cell proliferation, cell
death, and muscle contraction, are regulated by calcium
(Carlsen and Villarin, 2002; Kuklina and Shirshev, 2001;
Lewis, 2001; Orrenius et al., 2003), one of the most
important second messengers of the cell. Mobilized calcium
in immune cells may have different origins: the extracellular
medium, intracellular stores (endoplasmic reticulum, mito-
chondria, etc.), or both, via various mechanisms. Different
types of calcium channels are implicated in calcium
mobilization from the extracellular medium: (i) voltage-
operated calcium channels (VOCCs), type L, N, P/Q, or T,
largely present on excitable and neuronal cells; their
activation is mediated by depolarization of the plasma
membrane; (ii) receptor-operated calcium channels
(ROCCs), expressed on secretory cells and activated at
nerve terminals following the binding of specific ligands
(ATP, serotonin, glutamate, acetylcholine) to the extracel-
lular domain of the channels; (iii) store-operated calcium
channels (SOCCs), which are ubiquitous plasma membrane
calcium channels activated in response to the release of
intracellular calcium stores (Bootman et al., 2001). There-
fore, the study of the involvement of HIV-1 Tat protein in
calcium signaling in monocytes may provide some clue to
understanding the effect of this protein on immune
disorders.icrospectrofluorimetry (A) or confocal microscopy (B). (A) Monocytes
After two washes, monocytes were stimulated by Tat 1–86 from HIV-1 Lai
onds to the ratio of fluorescence emitted by stimulated cells to fluorescence
nt experiments, in which 34 F 8% of stimulated cells were positive. (B)
cal microscope (Zeiss, LSM 410) and stimulated by Tat (10 and 100 nM).
control) and after stimulation by Tat. The images presented here correspond
On the color ladder, blue represents low levels of Ca 2+ and red high levels.
X. Contreras et al. / Virology 332 (2005) 316–328318In this study, we have investigated the origin of the
calcium increase triggered by the HIV-1 Tat protein in
human monocytes, the nature, the expression, and the
functional state of the activated calcium channel, and the
involvement of calcium in Tat-induced TNF-a production.Fig. 2. HIV-1 Tat domain involved in the calcium signal triggered in human
monocytes. Monocytes were loaded with fluo-3-AM as described in the
legend of Fig. 1 and were then stimulated by different deleted HIV-1 SF-2
Tat mutants (A, Tat 1–45; B, Tat 20–72; C, Tat 30–72; D, GST) at the times
indicated by the arrows. Time course of fluorescence was then analyzed by
microspectrofluorimetry. Relative fluorescence corresponds to the ratio of
fluorescence emitted by stimulated cells to fluorescence emitted by resting
cells. Each panel is a representative result of three independent experiments,
in which 31 F 6% of stimulated cells were positive.Results
Tat protein induces calcium increase in human monocytes
Monocytes from healthy blood donors were stimulated
with recombinant Tat protein from HIV-1 Lai and SF2
isolates to determine whether these proteins induced a
calcium increase. The calcium transients were investigated
by following the variations in cytoplasmic-free calcium
concentrations ([Ca2+]i) at the cellular level by using two
complementary approaches, microspectrofluorimetry and
confocal microscopy, with the cell-permeant calcium
fluorescent probe fluo3-AM. Data presented in Fig. 1
show that the Tat protein elicited an increase in [Ca2+]i.
This increase was dose dependent, reaching 12% and 25%
for Tat at concentrations of 10 and 100 nM, respectively
(Fig. 1A). Interestingly, in addition to the similar dose-
response effect observed by confocal microscopy, the
most intense fluorescence appeared to be localized to the
cell membrane (Fig. 1B). As a positive control, ionomycin
(1 AM), a calcium ionophore, was used in all our
experiments. Under these conditions, we observed a
strong increase in [Ca2+]i that returned to baseline after
15-min stimulation (data not shown). These results show
that Tat induces a transient calcium increase in primary
monocytes.
Region 20–45 of HIV-1 Tat protein is involved in calcium
mobilization in monocytes
The Tat protein contains several identified functional
regions, including a cysteine-rich region (aa 20–31)
involved in the transactivating activity, a core region (aa
31–47) responsible for binding to RNA, a basic region
implicated in the nuclear localization of Tat (aa 48–57),
glutamic acid-rich region involved in virus replication (aa
57–76), and an RGD peptide (aa 78–80) that can interact
with integrins avh3 and a1h5.
To further characterize the implication of Tat protein in
calcium increase, we next performed experiments to
identify the domain of Tat that was involved. We thus
used different Tat deletion mutants, produced as gluta-
thione-S-transferase (GST) fusion proteins, including Tat
1–45 (RGD, glutamic, and basic domains deleted), Tat 20–
72 (N-terminal domain deleted), and Tat 30–72 (cysteine-
rich region deleted). The results depicted in Fig. 2 show
that Tat 1–45 and Tat 20–72 were still able to induce
calcium increase in monocytes, while no signal was
induced by Tat 30–72 or the control GST at the sameconcentrations. Taken together, these data indicate that the
active domain of Tat seems to be localized to region 20–45
of Tat.
X. Contreras et al. / Virology 332 (2005) 316–328 319The calcium increase in Tat-stimulated monocytes has an
extracellular origin
Calcium increase in human monocytes can have two
origins: (i) intracellular stocks (cellular organelles) that can
be activated mainly through IP3 or ryanodine receptors and
(ii) calcium from the extracellular medium that can enter
cells following the activation of membrane channels, such
as voltage-operated calcium channels (VOCCs), store-
operated calcium channels (SOCCs), and receptor-operated
calcium channels (ROCCs).
We thus sought to determine the origin of the calcium
increase observed in Tat-stimulated monocytes. To this
aim, we first used xestospongin C and TMB-8, inhibitors
of intracellular calcium stores stimulated, respectively, by
IP3 or ryanodine. These two inhibitors had no effect on
Tat-induced calcium increase in human monocytes (Figs.
3B and C). These results suggest that the calcium
mobilized in Tat-stimulated monocytes was not released
from intracellular stores. This conclusion cannot be
explained by the oligomerization status of Tat in the
presence or absence of calcium, since similar filtration
chromatography profiles on sephacryl S-100 column were
obtained when Tat was eluted in the presence or absence of
calcium (data not shown). Moreover, when primary
monocytes were stimulated by Tat in a calcium-free
medium, no increase in [Ca2+]i was observed (Fig. 3D),
whereas caffeine (10 mM), an activator of ryanodine
receptors, continued to stimulate the mobilization of
calcium (Fig. 3E) under these conditions.
Taken together, these results indicate that exposure of
primary monocytes to Tat protein allows calcium entry from
the extracellular medium, while calcium from inositol 1,4,5-
triphosphate(IP3)-regulated stores or caffeine-sensitive rya-
nodine receptor-regulated intracellular stores does not seem
to be triggered by Tat. We thus investigated the channels
involved at the cytoplasmic membrane of monocytes
responsible for this entry of calcium from the extracellular
medium.
DHP receptors are expressed in human monocytes
One putative candidate is the L-type calcium channel
(voltage-sensitive DHP receptors), a channel known to beFig. 3. Origin of the calcium influx stimulated by Tat in monocytes (see
Fig. 1). (A) Calcium increase following stimulation by HIV-1 SF2 Tat. (B
and C) Microspectrofluorimetric analysis of the involvement of intracellular
stores of calcium using Xestospongin C (1 AM, B) and TMB-8 (1 AM, C),
inhibitors of intracellular calcium stores stimulated, respectively, by IP3 and
ryanodine. To assess the role of the extracellular calcium, cells were
preincubated with calcium-free medium prior to stimulation by Tat (D) or
caffeine (E), an activation of intracellular calcium stores. Relative
fluorescence corresponds to the ratio of fluorescence emitted by stimulated
cells to fluorescence emitted by resting cells. Each panel is a representative
result of three independent experiments, in which 36 F 9% of stimulated
cells were positive. Similar results were obtained using HIV-1 Lai Tat.involved in the release of cytokines. L-type calcium
channels are composed of five subunits: a1 (190 kDa), a2
(143 kDa), h (55 kDa), g (30 kDa), and y (24–27 kDa)
(Campbell et al., 1988; Caterall et al., 1988, 1990; Taka-
Fig. 5. Identification of DHP receptors on the surface of human monocytes.
After preincubation of monocytes with ST-bodipy-DHP fluorescent dye
(used to stain the a1 subunit of DHP receptors), fluorescence was observed
with 546/590 nm excitation emission dichroic filters under a confocal
microscope (Zeiss, LSM 410). Cells were untreated (A) or preincubated
with BayK8644- (B), sense oligonucleotide for the a1D subunit of DHP
receptors (C), antisense oligonucleotides for a1D 10 AM (D), 1 AM (E), and
a1C 10 AM (F).
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individual gene, the a2 and y subunits are the processed
products of the same protein precursor (De Jongh et al.,
1990; Jay et al., 1991). Different isoforms of the a1 subunit
have been described: a1S (present in skeletal muscle), a1C
(in heart and smooth muscle), and a1D (in neurons and
neuroendocrine tissue).
We thus attempted to determine if these DHP receptors
were present. To this end, we analyzed their expression at
the transcriptional level by RT-PCR with oligonucleotides
from a conserved region of the a1 subunit. Fig. 4A shows
the amplification of a fragment of 700 nucleotides that
corresponds to the expected size. The specificity and
relevance of this result were further investigated by
subsequent cloning and sequencing of the amplified 700-
nucleotide fragment, which revealed a strong homology
(N98%) with a1D (data not shown), thus indicating that the
gene coding for the a1D subunit of DHP receptor was at
least transcribed.
To confirm the expression of DHP receptors at the
protein level, immunoblotting was performed with a
membrane protein extract from primary human monocytes
using an anti-a1D antibody raised against a synthetic
peptide corresponding to the 805–825 region of the a1D
subunit. A band was detected with an apparent molecular
weight of 200 kDa compatible with the a1 expected
molecular weight (Fig. 4B); moreover, when the same
experiments were performed with Cos33 cells, this band
was not detected. The specificity of this immunodetection
was further confirmed by competition with the soluble
synthetic peptide aa 805–825 (5 Ag/ml). After preincubation
of the cell protein extract with the peptide, the 200-kDa
band was totally absent (Fig. 4B, lane).
Finally, expression of DHP receptors at the monocyte
surface membrane was visualized by confocal microscopy.
We did this first by showing that dihydropyridine labeledFig. 4. Presence of DHP receptors in human monocytes. (A) RT-PCR using oligo
from human monocytes. (B) Western blot: 100 Ag of membrane proteins from hu
then an antibody raised against the a1D subunit of DHP receptors was used for rev
with its specific peptide (5 Ag/ml) was used.with a fluorescent probe (DHP-bodipy, 25 nM), a specific
ligand for DHP receptors, could bind to monocytes (Fig.
5). This binding was specific since it was strongly inhibited
by prior incubation of cells with the nonfluorescent agonist
of DHP receptors Bay K- (100 AM) (Fig. 5). Secondly, we
further demonstrated the relationship between the syn-
thesis, expression, and DHP-bodipy labeling in human
monocytes by targeting a1C and a1D mRNA with specific
antisense oligonucleotides. Primary human monocytes were
preincubated with a1C or a1D antisense oligonucleotides
(1, 10, and 20 AM), or with the corresponding sensenucleotides 5V-catgtagaagctgatgaa-3Vand 5V-ttcttcatgatgaacatctt-3Von mRNA
man monocytes and Cos33 cells was electrophoresed on an acrylamide gel,
elation. As a control for specificity, the same antibody previously incubated
Fig. 6. Functional DHP receptors on primary human monocytes. Monocytes
preincubated with fluo-3-AM as described in Fig. 1 were stimulated with
the DHP receptor agonist BayK8644- at the time indicated by the arrow and
relative fluorescence was analyzed by microspectrofluorimetry. This result
is a representative result of three independent experiments in which 42 F
3% of stimulated cells were positive.
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sion was evaluated by DHP-bodipy labeling. As shown in
Figs. 5C–F, treatment of monocytes with a1C or a1D
antisense oligonucleotides strongly inhibited DHP-bodipy
binding, even at 1 AM, with a1C oligonucleotides, and, in
a dose-dependent manner, with those related to a1D (Figs.
5D–E). Preincubation of monocytes with the control sense
sequence under the same conditions had no effect on the
binding of DHP-bodipy (Fig. 5C). We also used a panel of
antisense oligonucleotides directed against a1C and a1D
and found no inhibitory effect with some antisense
oligonucleotides corresponding to other regions of a1C
and a1D (Table 1).
These results show that DHP receptors are present on
human primary monocytes. That of these receptors were
functional as shown by the capacity of Bay K-, a DHP
receptor agonist, to increase intracellular calcium levels in
primary human monocytes (Fig. 6).
Taken together, these results strongly indicate the spe-
cific expression of functional DHP receptors on human
monocytes.
HIV-1 Tat protein mediates calcium entry via DHP
receptors
In order to evaluate the implication of DHP receptors in
the Tat-mediated signal, calcium signal was measured by
microspectrofluorimetry in monocytes loaded with fluo3-
AM previously incubated with two DHP receptor inhibitors,
nimodipine (1 AM) and calcicludine (0.1 AM), or for more
specific and selective effect with L-type calcium channel
antisense a1D oligonucleotides. Under these conditions, Tat
was no longer able to induce calcium increase (Figs. 7A–D),
thus suggesting the involvement of DHP receptors in the
mobilization of calcium induced by Tat.Table 1
Effect of anti-alpha1 antisense oligonucleotides on DHP receptor expression
Human primary monocytes
preincubated with
DHP-Bodipy
labeling of primary
human monocytes
 +
a1D antisense oligonucleotide no. 1
(cat cat cat cat cat cat cat (355–375 D38101))

a1D antisense oligonucleotide no. 2
(tta gcc ttc tct ctt tcc ttt gag aat tct cca cta
agg aca cc (1561–1604 D38101))

a1D antisense oligonucleotide no. 3
(atc tgg ttg tta tct ctc at (4615–4632 D38101))

a1C antisense oligonucleotide no. 1
(cct cgt gtt ttc att gac cat (1167–1187 L01776)

a1C antisense oligonucleotide no. 2 (cct tcc gtg
ctg ttg ctg ggc tca (5471–5494 L01776))
+
a1C antisense oligonucleotide no. 3
(act ctg ggg cac act tct tg (5450–5469 L01776))
+
a1D sense oligonucleotide (cca cag gaa tca cct ctt
aag agt ttc ctt tct ctc ttc cga tt)
+
BayK- (100 AM) Calcium increase through DHP receptors is involved in the
induction of production of TNF-a but not that of IL-6
resulting from HIV-1 Tat stimulation of human monocytes
The analysis by FACS of cytokine production showed
that 25.7% and 42.52% of the Tat-stimulated monocytes
produced TNF-a and IL-6 (Fig. 8B). More interestingly,
blockade of DHP receptor expression with antisense a1D
oligonucleotides or function with nimodipine resulted in a
considerable inhibition (92.6% and 77.1%, respectively) of
TNF-a-positive cells, whereas the population of IL-6-
producing monocytes remained comparable to the positive
control, performed in the absence of inhibitors (Figs. 8C and
D). No inhibition of TNF-a was observed when the same
experiments were performed with the corresponding sense
oligonucleotides (Fig. 8E). In agreement with these results,
a significant inhibition of TNF-a, but not IL-10, production
in cell supernatants of Tat-stimulated monocytes in the
presence of nimodipine was obtained (Fig. 8G and data not
shown). On the other hand, we have shown that blockade of
DHP-R by nimodipine does not interfere with CD4 or HLA-
DR expression nor with the susceptibility of monocytes to
be infected by the macrophage tropic HIV-1 BaL (data not
shown).
Overall, these results show the presence in primary
human monocytes of DHP receptors that are composed of
the a1D subunit, which can be specifically activated by
HIV-1 Tat protein to induce TNF-a, a pro-inflammatory
cytokine that plays an important role in the pathogenesis of
HIV-1 infection.Discussion
A variety of functions have been associated with HIV-1
Tat protein, including induction of apoptosis (Westendorp et
al., 1995b), immunosuppressions (Badou et al., 2000;
Shearer and Clerici, 1993), stimulation or inhibition of
cytokine production (Brady et al., 1995; Nath et al., 1999;
Fig. 7. Microspectrofluorimetric demonstration of the involvement of DHP receptors in the calcium increase in monocytes following stimulation by Tat (see
Fig. 1). Monocytes were preincubated with DHP receptor inhibitors (A: nimodipine, B: calcicludine) or antisense oligonucleotides directed against the a1D
subunit of DHP Receptors (C) prior to stimulation by HIV-1 SF-2 Tat. As a negative control, the corresponding sense oligonucleotide was used (D). Relative
fluorescence corresponds to the ratio of fluorescence emitted by stimulated cells to fluorescence emitted by resting cells. Each panel is a representative result of
three independent experiments in which 33 F 7% of stimulated cells were positive. Similar results were obtained using HIV-1 Lai Tat.
X. Contreras et al. / Virology 332 (2005) 316–328322Rautonen et al., 1994; Sharma et al., 1995; Zocchi et al.,
1998), vaccinating properties (Fanales-Belasio et al., 2002a,
2002b), and mobilization calcium (Albini et al., 1998;
Mayne et al., 2000). The aim of this study was to
characterize the origin of mobilized calcium, the nature
of the calcium channel activated, and the role of calcium
in Tat-induced TNF-a production in human primary
monocytes.
Recently, we investigated the signaling pathways trig-
gered by Tat in human monocytes that lead to TNF-a
production (Bennasser et al., 2002). We showed that the
PKC and calcium pathways are required for TNF-a
production, whereas the PKA pathway does not seem to
be implicated. Downstream of PKC, we showed that
activation of NF-nB is essential, whereas ERK1/2 MAP
kinases, even though they are activated by Tat, are not
directly involved in the signaling leading to TNF-a
production.
In this work, we showed, as reported by Albini et al.
(1998) for macrophages, astrocytes, and neurones, and by
Canani et al. (2003) for human intestinal epithelial cells, that
the Tat protein induces an increase in the concentration of
cytoplasmic calcium in primary human monocytes and that
this may then be used as a second messenger for activating
signaling pathways leading to cytokine gene expression and
the production of TNF-a. However, the findings of Albini et
al., Canani et al., and ourselves differ from the data of Poggi
et al. (1998, 2002) in two respects: the opposite effect of Tat
on calcium mobilization and the proposed active domain of
Tat (aa 65–80). This latter result is in disagreement with thecommon active domain (Tat 24–51 and Tat 20–45)
determined, respectively, by Albini et al. and by us and
with data showing that the Tat deletion mutant D31–61 can
no longer trigger a rise in intracellular calcium (Self et al.,
2004). Moreover, the recent data of Fanales-Belasio et al.
(2002a, 2002b), who found that Tat can stimulate IL-12
production and MHC antigen upregulation, do not support
either the hypothesis advanced by Poggi et al. either.
Another more fundamental question concerns the origin
of the mobilized calcium. Our results indicate that it seems
to have an extracellular origin, since (i) no signal was
observed when monocytes were stimulated with Tat in a
calcium-free medium, (ii) the calcium increase induced by
Tat was not affected when stimulation was performed in the
presence of Xestospongin C or TMB8, two inhibitors of
intracellular stores, mediated, respectively, by IP3 and
ryanodine receptors. The latter conclusion disagrees with
the reports of Mayne et al. showing the implication of IP3-
sensitive stores in the calcium increase generated by Tat in
macrophages (Mayne et al., 2000) and astrocytes (Mayne et
al., 1998). On the other hand, our results do agree with those
of Albini et al. (1998), who showed a strong implication of
extracellular calcium in the signal induced by Tat. This
contradiction could be due in part to the different cell types
and sources of Tat used in each study.
At the structural and functional levels, molecular,
biochemical, and immunochemical studies have shown that
DHP receptors consist of complexes formed by five protein
subunits. The a subunit (200 kDa) represents the main part
of the channel. At least six isoforms of the a subunit have
Fig. 8. Cytokine expression in HIV-1 SF-2 Tat-stimulated monocytes. Monocytes (106 cells), stimulated or not, were treated with monensin (6 h) in order to
block cytokine secretion prior to their analysis by FACS as described in Materials and methods. Briefly, cells were stained with anti-CD14 monoclonal
antibody (APC), fixed with formaldehyde, and then stained with anti-TNF-a and anti-IL-6 monoclonal antibodies. Only CD14+ cells (monocytes) were
analyzed for the presence of these cytokines. (A) Control unstimulated cells; (B–D) HIV-1 Tat stimulated cells (10 nM) pretreated with nimodipine, 1 AM; (C)
antisense oligonucleotides for DHP receptors, 10 AM; (D) or control sense oligonucleotides (E). Results are quantified in the histogram F. In G, monocytes (106
cells), pretreated or not with nimodipine (10, 1, and 0.1 AM), were stimulated by Tat (1 nM). Supernatants were collected 6 h later and TNF-a concentration
was assessed by ELISA. Data from one donor are shown, representative of three different experiments carried out on cells from three different donors. Similar
results were obtained using HIV-1 Lai Tat.
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DHP receptor isoforms in skeletal and cardiac muscle,
respectively. This variety underlies the characteristic electro-
physiological parameters of voltage-dependent calcium
channels (VDCCs) (Jones, 1998). In addition to the a1
subunit, the DHP receptor channel consists of the h subunit
(60 kDa) and a disulfide-connecting complex of a2 and y
subunits (170 kDa). The a1 subunit is the receptor forcalcium antagonist and can function as a voltage-gated
channel. DHP receptor channel activity is in part regulated
by phosphorylation via protein kinase. In addition to the
modulation of DHP receptor channels by PKC (Savignac et
al., 2001), other protein kinases were also implied, including
cyclic GMP-dependent protein kinase, which seems to act
by decreasing L-type calcium channel current (Jiang et al.,
2000).
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type calcium channels), mostly a1D, on primary human
monocytes as shown by RT-PCR, SDS-PAGE, and Western
blot analysis, and inhibition of DHP receptor expression by
specific antisense oligonucleotides.
In addition to their presence in primary human mono-
cytes, several lines of evidence support that these channels
are also functional. Firstly, the stimulation of human
monocytes by BayK8644-, a DHP receptor agonist, induced
an intracytoplasmic increase of calcium level similar to that
obtained with Tat. Secondly, preincubation of monocytes
with nimodipine or calcicludine, two antagonists of DHP
receptors, completely blocked the ability of Tat to stimulate
calcium entry into cells. It is interesting to note that these
channels seem to be voltage independent since no calcium
increase was induced following stimulation of monocytes
with 50 mM KCl (data not shown). This statement is in
agreement with previous results showing that L-type
calcium channels (DHP receptors) in immune cells, includ-
ing dendritic and NK cells, are also independent of voltage
(Poggi et al., 1998; Zocchi et al., 1998). More recently, it
was shown that DHP receptors can be selectively expressed
on Th2 but not Th1 T lymphocytes (Savignac et al., 2001),
thus suggesting that DHP receptors are directly implicated
in the production of IL-4 cytokine and in the modulation of
Th2 effector function. Interestingly, the same group using
the Norway rat model described a direct relationship
between DHP-sensitive calcium channels and the auto-
immune disease induced by chronic injection of gold salts.
Indeed, treatment of rats with calcium channel blockers
appeared to prevent development of the disease (Fournie et
al., 2002).
Finally, we have shown that Tat-induced calcium
mobilization and TNF-a production are entirely mediated
via DHP receptors, since there was a total inhibition of its
release in the presence of nimodipine or calcicludine,
inhibitors of DHP receptors, or in the presence of specific
a1D antisense oligonucleotides. The capacity of Tat 1–45 to
stimulate DHP receptor is also in agreement with its ability
to stimulate TNF-a production (data not shown).
Taken together, our results show that DHP receptors are
expressed at the membrane of human monocytes, are
apparently functional, and are recruited for the mediation
of a calcium increase following stimulation by HIV-1 Tat
protein.
We show in the present study that TNF-a is produced by
human monocytes as a consequence of the mobilization of
calcium triggered by Tat by recruiting DHP receptors. This
production is observed with as low a concentration as 1–10
nM of Tat protein. Soluble HIV-1 Tat protein has been
detected in sera of HIV-1-infected patients at the nanomolar
level (Westendorp et al., 1995b; Xiao et al., 2000), but this
concentration may be underestimated, since Tat may be
trapped by its potential receptors, particularly the heparan
sulfates, molecules widely expressed on cell surfaces
(Albini et al., 1996). Furthermore, this concentration wouldbe higher near productively infected cells (Ensoli et al.,
1993) and can act on other cells, whether they are infected
or not (Mann and Frankel, 1991).
TNF-a is believed to contribute to the development of
neurological diseases, known as HIV-associated dementia
(HAD), associated with HIV (Talley et al., 1995). About
20% and 80%, respectively, of HIV-1 infected adults and
children develop some level of HAD (Tardieu et al.,
2000). The extracellular Tat released in the central nervous
system by infected infiltrating monocytes/macrophages and
microglial cells could induce the toxic cytokine TNF-a,
which can act directly on adjacent neurons, oligodendro-
cytes, and astrocytes to cause neurotoxicity and neuro-
degeneration (Talley et al., 1995). By inducing TNF-a, Tat
appears to contribute actively as a pathogenic and
immunosuppressive factor to disease progression. As Tat
protein is necessary for HIV-1 replication and is involved
in a number of physiopathological effects, therapeutic
approaches targeting Tat could be particularly effective in
reducing lower the physiopathological effects of HIV-1
infection.Materials and methods
Cells and reagents
PBMCs were isolated from buffy coats of healthy HIV-
negative donors in a Ficoll density gradient (Pharmacia,
Piscataway, NJ). PBMCs were resuspended in 60/30
complete medium (60% AIMV and 30% Iscove [GIBCO-
BRL, Grand Island, NY]) containing penicillin (100 IU/ml),
streptomycin (100Ag/ml), and 10% FCS. PBMCs were
plated at a density of 106cells/well in 24-well Primaria
(Becton Dickinson, Rutherford, NJ) tissue culture plates.
After 24-h culture at 37 8C in 5% CO2, nonadherent cells
were removed, the remaining cells were washed twice, and
then incubated with the different compounds tested. Mono-
cytes were 94% pure as tested by FACs with anti-CD14
antibody.
Recombinant HIV-1 Tat protein was obtained from the
Agence Nationale de la Recherche sur le SIDA (Paris,
France). The level of endotoxin contamination in purified
HIV-1 Tat was assessed using the limulus amebocyte lysate
assay (Bio-Sepra, Villeneuve-la-Garenne, France).
HIV-1 Tat mutants were produced as glutathione-S-
transferase (GST) fusion proteins in Escherichia coli. Wild-
type GST-Tat 1–101 and Tat-deleted mutants GST-Tat 1–45,
GST-Tat 20–72, and GST-Tat 30–72 were purified as
described (Benkirane et al., 1998). As control, GST was
purified under the same conditions and used in the same
experiments. All these constructions were LPS free (b0.3
EU/Ag) and biologically active, as described (Sabatier et al.,
1991).
The calcium signaling inhibitors Nimodipine, Calciclu-
dine, Xestospongin C, TMB-8 are from Calbiochem. A
X. Contreras et al. / Virology 332 (2005) 316–328 325putative cytotoxic effect of the different inhibitors was
tested by the trypan blue dye exclusion assay and none was
found to be cytotoxic (viability was N90%) at the concen-
trations used.
Calcium signaling
Microspectrofluorimetry
Intracellular calcium (Ca2+) concentrations were deter-
mined by emission microspectrofluorimetry as previously
described (Badou et al., 2000). Monocytes, untreated or
preincubated for 1 h with the inhibitors of calcium
signaling or in calcium-free medium, were incubated with
5 AM 3-fluo-acetoxymethylester (AM; Molecular Probes,
Leiden, The Netherlands) for 30 min at 37 8C. Intra-
cellular Ca2+ concentrations were measured in cells
stimulated by Tat (10 or 100 nM) or in different Tat
mutants (50 nM); cells treated with 1 AM ionomycin
(Sigma) were used as positive control in HBSS medium
supplemented with 1% FCS. Ionomycin was initially
dissolved in DMSO at a concentration of 2 mM. Cell
preparations were placed on the stage of an inverted
Diaphot microscope (Nikon) and observed with a 40
objective. The excitation wavelength was 490 nm with a
525-nm barrier filter. Fluorescence was detected by an
intensified charge-coupled device fitted with a 2400-80
camera (Hamamatsu photonics, Hamamatsu, Japan). At the
magnification used (40), a field of 200  200 Am was
recorded by the camera. Three to five fields were observed
for each type of experiment, and for each field 12
windows (9 Am) were selected on different cells and
analyzed for fluorescence. Images were captured at
intervals of 5 s and processed with the Argus 50 image
processing system (Hamamatsu photonics) or simple PCI
software (Compix USA). Time courses of Ca2+ mobiliza-
tion in cells were analyzed with argus 50 or simple PCI
software. Data are presented as the ratio of fluorescence
(F) in stimulated cells to fluorescence (F0) at the baseline
level. Cells were scored as positive if the variation in
fluorescence intensity was more than 2% above the
baseline level to erase the background signal.
Confocal microscopy
Monocytes loaded with fluo-3-AM as described above
were placed under a confocal microscope in HBSS medium
containing 1% FCS. The change in calcium concentration
was measured in cells stimulated by Tat (10 or 100 nM)
using a confocal microscope (Zeiss, LSM 410). The
fluorescent probe was excited using an Argon laser with a
wavelength of 488 nm. The images were taken every 5 s
from the equatorial plane of cells.
Treatment of monocytes with oligonucleotides
Oligonucleotides were synthesized by MWG (MWG,
Germany). The sequences of antisense and sense oligonu-cleotides are listed in Table 1. Sequences specific for a1C
and a1D subunits of DHP receptors were selected from
sequences of mRNA that are unique and specific using
Blast. Monocytes were plated at a density of 106 cells/ml in
Iscove/AIMV supplemented with 1% FCS and treated with
antisense or sense oligonucleotides for 12 h. Then 10% FCS
was added to the medium and the monocytes were cultured
for a further period of 12 h.
mRNA expression
Total mRNA was extracted and reverse transcribed as
described elsewhere (Jiang et al., 2000). LTCCs were
sought by using the sense 5V-TTCTTCATGATGAA-
CATCTT-3V and antisense 5V-CATGTAGAAGCTGAT-
GAA-3Vprimers (Catterall et al., 1988), which correspond
to conserved regions IIIS6 and IVS6 of each of the a1
isoforms. cDNAs were amplified in a 25-Al reaction volume
containing 1 AM of each dNTP (dATP, dTTP, dGTP, and
dCTP) (Pharmacia, Uppsala, Sweden), 0.5 AM of each
oligonucleotide primer, 2 mM MgCl2, 1 U of Taq-DNA
polymerase (GIBCO), and 2.5 Al of PCR buffer 10
(GIBCO). Reactions were performed in a DNA thermal
cycler (Perkin-Elmer) for 40 cycles: 45 s at 95 8C, 45 s at
51 8C, and 1 min at 72 8C, preceded by an initial
denaturation step (1 min at 93 8C). Ten percent of the
products were then subjected to a nested PCR using the
sense 5V-AAGAACTGTGAGCTGGACAA-3Vand the anti-
sense 5VGATCTCCTGCCAGGCCTC-3Vprimers. Reactions
were performed in a DNA thermal cycler (Perkin-Elmer) for
30 cycles: 45 s at 95 8C, 45 s at 62 8C, and 1 min at 72 8C,
preceded by an initial denaturation step (1 min at 93 8C).
The products were analyzed by electrophoresis on a 1.5%
agarose gel. The identity of the PCR products with LTCC
sequences was confirmed by sequencing.
Staining of DHP receptors
ST-BODIPY dihydropyridine (Molecular Probes) was
used to detect LTCC (De Jongh et al., 1990) at the surface
of primary human monocytes by fluorescent confocal
microscopy. Monocytes were incubated with 250 nM ST-
BODIPY dihydropyridine for 5 min at 37 8C in the dark.
To determine nonspecific ST-BODIPY dihydropyridine
binding, cells were preincubated for 30 min at 37 8C with
100 AM Bay K- before adding the fluorescent probe
(Leclerc et al., 1995). Controls included omission of the
fluorescent dye, with or without preincubation with Bay K-.
Cells were washed, placed on the stage of an inverted
microscope (Nikon, Diaphot) of a laser confocal micro-
scope (LSM, 410, Zeiss), and observed with a Zeiss 63 X/
1.4 numerical aperture objective, illuminated by a 100-W
xenon lamp. Excitation was provided by a helium-neon
laser at 543 nm and barrier filter at 580 nm. Images were
processed, integrated, and expressed on a 256-pseudocolor
scale.
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Isolation of cytoplasmic and membrane protein extracts
Monocytes were harvested and rapidly lysed at 4 8C in
100 Al of hypotonic buffer A (20 mM Tris–HCl, 2 mM
EDTA, 1 mM DTT, 10 Ag/ml leupeptin, 1 mM PMSF; pH
7.5) by repeated aspiration through a syringe fitted with a
21-gauge needle. After addition of 300-Al ice-cold sample
buffer B (20 mM Tris–HCl, 2 mM EDTA, 1 mM DTT, 10
Ag/ml leupeptin, 1 mM PMSF, 0.33 M sucrose; pH 7.5), the
lysate was centrifuged at 100,000  g at 4 8C for 40 min.
The supernatant corresponding to the cytoplasm was
collected; proteins were quantified with the Bradford assay
and stored at 20 8C. The membrane pellets were
solubilized in 50 Al of cold sample buffer B containing
1% Triton X-100, sonicated (1 min, power 2.5), and stored
at 20 8C.
Western blot analysis of a1D subunit of DHP receptors
Equal amounts of protein (100 Ag) were subjected to
10% SDS-PAGE and separated proteins were transferred to
nitrocellulose membranes. Immunoblotting was conducted
with anti-a1D antibody (1:1000) (Calbiochem). The
membrane was blocked with 5% milk in Tris-buffered
saline with 0.05% Tween 20 (TTBS) for 1 h, washed four
times with TTBS, and incubated with the primary antibody
for 2 h. Immunoreactive bands were detected by incuba-
tion for 2 h with anti-rabbit immunoglobulins conjugated
with horseradish peroxidase (1:1000) (DAKO A/S, Ros-
kilde, Denmark). Membranes were visualized using a
chemiluminescent substrate (Pierce, Rockford, IL).
Immunostaining and flow cytometric analysis of
intracellular cytokines
Monocytes (106) isolated from buffy coats cultured in
AIMV-Iscove medium supplemented with 1% FCS were
preincubated with the appropriate inhibitors prior to
stimulation with 10 nM of Tat protein. Monensin was then
added to block protein secretion and cells were collected
after 6 h of stimulation for the assessment of the presence of
TNF-a and IL-6. Cells were then collected, washed in
CellWASH (optimized phosphate-buffered saline for cell
preparation and cell washing containing NaCl, Na2HPO4,
NaH2PO4, NaN3, pH 7.2 F 0.1 at 25 8C; BDIS).
Subsequently, they were resuspended in 100 Al CellWASH
and stained at 4 8C for 20 min with an anti-CD14
monoclonal antibody conjugated to allophycocyanin
(APC). After two further washes with CellWASH, the cells
were fixed for 10 min in 200 Al CellWASH containing 1.5%
formaldehyde. Finally, the cells were washed twice and
resuspended in CellWASH with anti-TNF-a and anti-IL-6
antibodies conjugated to phycoerythrin (PE) and fluorescein
isothiocyanate (FITC), respectively, to stain intracytoplas-
mic cytokines. This mixture was incubated for 30 min at
4 8C at appropriate concentrations. The cells were thenwashed twice in CellWASH and were then ready for
analysis.
ELISA TNF-a
Monocytes (106) isolated from buffy coats cultured in
AIMV-Iscove medium supplemented with 1% FCS were
preincubated with the appropriate inhibitors prior to
stimulation with 1 nM of Tat protein. Supernatants were
collected 6 h later and TNF-a was quantified using ELISA
TNF-a kit (ibioscience).Acknowledgments
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